Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years (Q37316006)

19 August 2017

1 reference

title

Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years (English)

1 reference

19 August 2017

2

Nicola P Klein

1 reference

19 August 2017

Wayde M Weston

1

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Expert Review of Vaccines

19 August 2017

published in

1 reference

19 August 2017

volume

7

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

1309-1320

1 reference

Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vacc

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Use of combination vaccines is associated with improved coverage rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4–6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.9.1309

10.1586/14760584.7.9.1309

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference